Liraglutide-induced effects on energy intake and glycemic profile are independent of total and intact GDF-15 levels in subjects with obesity and diabetes-Reference-Cited by-同舟云学术

Liraglutide-induced effects on energy intake and glycemic profile are independent of total and intact GDF-15 levels in subjects with obesity and diabetes

Published:2022-09 Issue:5 Volume:48 Page:101369
ISSN:1262-3636
Container-title:Diabetes & Metabolism
language:en
Short-container-title:Diabetes & Metabolism

Author:

Valenzuela-Vallejo Laura^ORCID,Chrysafi Pavlina,Mantzoros Christos S.

Publisher

Elsevier BV

Subject

Endocrinology,General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference15 articles.

1. GDF15 as a central mediator for integrated stress response and a promising therapeutic molecule for metabolic disorders and NASH;Kim;Biochim Biophys Acta Gen Subj,2021

2. GFRAL is the receptor for GDF15 and the ligand promotes weight loss in mice and nonhuman primates;Mullican;Nat Med,2017

3. Long-acting MIC-1/GDF15 molecules to treat obesity: evidence from mice to monkeys;Xiong;Sci Transl Med,2017

4. Growth differentiation factor 15 as a potential therapeutic for treating obesity;Hale;Mol Metab,2021

5. Growth differentiation factor 15 (GDF15) and semaglutide inhibit food intake and body weight through largely distinct, additive mechanisms;Ghidewon;Diabetes Obes Metab,2022

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Total and H-specific GDF-15 levels increase in caloric deprivation independently of leptin in humans;Nature Communications;2024-06-18

2. Circulating total and H-specific GDF15 levels are elevated in subjects with MASLD but not in hyperlipidemic but otherwise metabolically healthy subjects with obesity;Cardiovascular Diabetology;2024-05-18

3. Total and H‐specific growth/differentiation factor 15 levels are unaffected by liraglutide or naltrexone/bupropion administration;Diabetes, Obesity and Metabolism;2024-05-17

4. Thyroid function, adipokines and mitokines in metabolic dysfunction‐associated steatohepatitis: A multi‐centre biopsy‐based observational study;Liver International;2024-01-23

5. Circulating hormones in biopsy-proven steatotic liver disease and steatohepatitis: A Multicenter Observational Study;Metabolism;2023-11